D. E. Shaw & Co. Inc. Has $21.54 Million Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

D. E. Shaw & Co. Inc. lifted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 502.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 543,346 shares of the company's stock after purchasing an additional 453,093 shares during the quarter. D. E. Shaw & Co. Inc. owned about 0.58% of Acadia Healthcare worth $21,544,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Tidal Investments LLC grew its position in Acadia Healthcare by 7.9% in the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company's stock valued at $296,000 after buying an additional 340 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of Acadia Healthcare by 273.1% in the third quarter. Franklin Resources Inc. now owns 105,228 shares of the company's stock valued at $6,673,000 after buying an additional 77,027 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company's stock valued at $41,653,000 after buying an additional 13,368 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after buying an additional 454,044 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares in the last quarter.

Analysts Set New Price Targets

ACHC has been the topic of a number of research analyst reports. Mizuho decreased their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday. Barclays dropped their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday. Royal Bank of Canada lowered their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Bank of America reduced their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. Finally, KeyCorp lowered their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Stock Down 0.3%

NASDAQ ACHC traded down $0.08 during trading on Thursday, hitting $25.64. 2,404,357 shares of the company traded hands, compared to its average volume of 1,696,832. Acadia Healthcare Company, Inc. has a 12 month low of $20.36 and a 12 month high of $82.41. The business has a fifty day simple moving average of $26.34 and a 200 day simple moving average of $36.01. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $2.36 billion, a P/E ratio of 8.41, a PEG ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company's quarterly revenue was up .3% on a year-over-year basis. During the same period in the previous year, the business earned $0.84 earnings per share. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.